Cargando…
PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction
Autores principales: | Li, Ming, Zhang, Weiwei, Zhang, Shenjun, Wang, Changhui, Lin, Yinping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240659/ https://www.ncbi.nlm.nih.gov/pubmed/37283802 http://dx.doi.org/10.7150/jca.85747 |
Ejemplares similares
-
PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer
por: Li, Ming, et al.
Publicado: (2017) -
Retraction Note: Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3
por: Li, Ming, et al.
Publicado: (2021) -
[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2023) -
Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma
por: Zhu, Bing, et al.
Publicado: (2023) -
Retraction: Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small cell lung cancer
Publicado: (2019)